loading
전일 마감가:
$3.97
열려 있는:
$3.93
하루 거래량:
90,784
Relative Volume:
0.80
시가총액:
$34.04M
수익:
$140.46M
순이익/손실:
$-146.34M
주가수익비율:
-3.1024
EPS:
-1.27
순현금흐름:
$-117.73M
1주 성능:
+0.25%
1개월 성능:
-15.27%
6개월 성능:
-58.37%
1년 성능:
-68.67%
1일 변동 폭
Value
$3.83
$4.07
1주일 범위
Value
$3.81
$4.35
52주 변동 폭
Value
$3.51
$16.95

Karyopharm Therapeutics Inc Stock (KPTI) Company Profile

Name
명칭
Karyopharm Therapeutics Inc
Name
전화
617-658-0600
Name
주소
85 WELLS AVENUE, NEWTON, MA
Name
직원
279
Name
트위터
@Karyopharm
Name
다음 수익 날짜
2024-11-05
Name
최신 SEC 제출 서류
Name
KPTI's Discussions on Twitter

KPTI을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
KPTI
Karyopharm Therapeutics Inc
3.94 34.82M 140.46M -146.34M -117.73M -1.27
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
366.54 98.88B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.00 58.84B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
438.93 56.12B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
661.83 41.20B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
288.18 35.49B 3.81B -644.79M -669.77M -6.24

Karyopharm Therapeutics Inc Stock (KPTI) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-16 다운그레이드 H.C. Wainwright Buy → Neutral
2025-07-11 재개 H.C. Wainwright Buy
2023-01-19 개시 Piper Sandler Overweight
2022-11-04 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2022-02-09 업그레이드 JP Morgan Underweight → Neutral
2021-11-19 재개 Morgan Stanley Equal-Weight
2021-08-06 다운그레이드 JP Morgan Overweight → Neutral
2021-08-06 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2021-08-06 다운그레이드 SVB Leerink Outperform → Mkt Perform
2020-07-02 개시 Morgan Stanley Overweight
2020-03-04 개시 Barclays Overweight
2020-01-17 다운그레이드 Wedbush Outperform → Neutral
2019-07-23 업그레이드 JP Morgan Neutral → Overweight
2019-07-05 재확인 H.C. Wainwright Buy
2019-07-05 재확인 Robert W. Baird Outperform
2019-03-01 다운그레이드 JP Morgan Overweight → Neutral
2019-02-28 재확인 BofA/Merrill Underperform
2019-02-27 다운그레이드 BofA/Merrill Neutral → Underperform
2019-01-03 업그레이드 BofA/Merrill Underperform → Neutral
2018-12-03 개시 B. Riley FBR Buy
2018-11-09 업그레이드 Wedbush Neutral → Outperform
2018-05-24 다운그레이드 Wedbush Outperform → Neutral
2018-04-02 재개 Leerink Partners Outperform
2017-11-15 재개 H.C. Wainwright Buy
2017-09-15 개시 RBC Capital Mkts Outperform
2016-09-08 재확인 H.C. Wainwright Buy
2016-08-30 업그레이드 Jefferies Hold → Buy
2016-08-18 개시 H.C. Wainwright Buy
2016-06-28 개시 Robert W. Baird Outperform
모두보기

Karyopharm Therapeutics Inc 주식(KPTI)의 최신 뉴스

pulisher
Aug 08, 2025

Earnings Outlook For Karyopharm Therapeutics - 富途牛牛

Aug 08, 2025
pulisher
Aug 08, 2025

Visual trend scoring systems applied to Karyopharm Therapeutics Inc.Technical Reversal Setup with Risk Limits - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Automated trading signals detected on Karyopharm Therapeutics Inc.Free Community Strategy With High Win Rate - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Chart based exit strategy for Karyopharm Therapeutics Inc.Secure Entry Point Finder with Analysis - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

How moving averages guide Karyopharm Therapeutics Inc. tradingMarket Timing Strategy with Technical Filters - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Karyopharm Therapeutics Inc expected to post a loss of $4.10 a shareEarnings Preview - TradingView

Aug 08, 2025
pulisher
Aug 08, 2025

Tick level data insight on Karyopharm Therapeutics Inc. volatilityTechnical Trade Plan with Entry Checklist - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

How Karyopharm Therapeutics Inc. stock reacts to Fed policy changesFree Weekly Potential Breakout Stock List - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Karyopharm Therapeutics Inc (KPTI) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance

Aug 08, 2025
pulisher
Aug 07, 2025

What data driven models say about Karyopharm Therapeutics Inc.’s futureBuy Strategy Review With Performance Summary - Newser

Aug 07, 2025
pulisher
Aug 07, 2025

Layoff Tracker: 60 Biotech Staff Lose Jobs as Poseida, Alltrna Reduce Workforce - BioSpace

Aug 07, 2025
pulisher
Aug 06, 2025

Karyopharm to Report Second Quarter 2025 Financial Results on August 11, 2025 - Eastern Progress

Aug 06, 2025
pulisher
Aug 06, 2025

Karyopharm Therapeutics Inc. stock prediction for this weekAI Swing Strategy Signal Forecasting System - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Candlestick signals on Karyopharm Therapeutics Inc. stock todayHigh Reward Picks with Tight Risk Control - Newser

Aug 06, 2025
pulisher
Aug 05, 2025

Is a relief rally coming for Karyopharm Therapeutics Inc. holdersFast Entry Strategy with Price Prediction - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

Karyopharm to Report Second Quarter 2025 Financial Results on Au - GuruFocus

Aug 05, 2025
pulisher
Aug 05, 2025

Will Karyopharm Therapeutics Inc. stock split in the near futureStock Price Prediction Using AI Tools - Newser

Aug 05, 2025
pulisher
Aug 04, 2025

Karyopharm Therapeutics Inc. Sees Spike in Bullish Option FlowPattern Alert With ROI Driven Strategy Shared - beatles.ru

Aug 04, 2025
pulisher
Aug 03, 2025

Is Karyopharm Therapeutics Inc. a growth stock or a value stockTriple-digit profit margins - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Why is Karyopharm Therapeutics Inc. stock attracting strong analyst attentionUnlock real-time trading signals for gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes Karyopharm Therapeutics Inc. stock price move sharplyUnlock powerful portfolio management tools - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Karyopharm Therapeutics Inc. compare to its industry peersAchieve impressive returns with smart timing - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in Karyopharm Therapeutics Inc. stockBuild a winning portfolio with smart picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Will Karyopharm Therapeutics Inc. see short term momentumFree AI Screening for Swing Trade Picks - Newser

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Karyopharm Therapeutics Inc. stockFree Daily Trading Room Entry - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Should I hold or sell Karyopharm Therapeutics Inc. stock in 2025Overwhelming financial success - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

When is Karyopharm Therapeutics Inc. stock expected to show significant growthCapitalize on fast-moving stock opportunities - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Eastern Progress

Aug 02, 2025
pulisher
Aug 02, 2025

Is Karyopharm Therapeutics Inc. stock overvalued or undervaluedRapid portfolio appreciation - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Why Karyopharm Therapeutics Inc. stock attracts strong analyst attentionEntry Signal Momentum Tracker Review - beatles.ru

Aug 02, 2025
pulisher
Aug 02, 2025

Karyopharm's Strategic Use of Inducement Grants to Attract Talent in a Competitive Biotech Landscape - AInvest

Aug 02, 2025
pulisher
Aug 01, 2025

Karyopharm Therapeutics Awards 333 Restricted Stock Units to New Employee - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

KARYOPHARM THERAPEUTICS Earnings Preview: Recent $KPTI Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Aug 01, 2025
pulisher
Jul 30, 2025

Published on: 2025-07-30 09:02:26 - metal.it

Jul 30, 2025
pulisher
Jul 29, 2025

Karyopharm Therapeutics (KPTI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo Finance

Jul 29, 2025
pulisher
Jul 28, 2025

What makes Karyopharm Therapeutics Inc. stock attractive to long term investorsGrowth Based Stock Signal Screener Updated - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Karyopharm Shares Slide After Financing Efforts Stall, Strategic Review Underway - MSN

Jul 28, 2025
pulisher
Jul 28, 2025

How many analysts rate Karyopharm Therapeutics Inc. as a “Buy”Invest smarter with expert trading signals - Jammu Links News

Jul 28, 2025
pulisher
Jul 28, 2025

How strong is Karyopharm Therapeutics Inc. company’s balance sheetPost Market Review For 2025 - Jammu Links News

Jul 28, 2025
pulisher
Jul 28, 2025

Has Karyopharm Therapeutics Inc. found a price floorDaily Market Momentum and Pressure Analysis - Newser

Jul 28, 2025

Karyopharm Therapeutics Inc (KPTI) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$78.39
price up icon 0.24%
$37.58
price up icon 1.54%
$109.55
price up icon 0.23%
$28.66
price up icon 2.10%
$111.66
price up icon 0.28%
biotechnology ONC
$288.18
price down icon 3.39%
자본화:     |  볼륨(24시간):